Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Artemisinin
DIETARY_SUPPLEMENT
4 trials
Sponsors
Sheppard Pratt Health System
, Beijing HuiLongGuan Hospital
, Oncotelic Inc.
, Mateon Therapeutics
Conditions
COVID-19
Covid19
Schizoaffective Disorder
Schizophrenia
Phase 2
A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects
NCT04801017
Oncotelic Inc.
COVID-19
Start: 2021-04-30
End: 2021-10-31
Target: 18
Updated: 2021-03-16
Phase 3
Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
Completed
NCT01391403
Beijing HuiLongGuan Hospital
Schizophrenia
Start: 2008-09-30
End: 2011-05-31
Updated: 2016-07-12
Phase 4
A Study to Evaluate the Safety and Efficacy of Artemisinin- a Herbal Supplement on COVID-19 Subjects
Completed
NCT05004753
Mateon Therapeutics
Covid19
Start: 2020-09-30
End: 2021-04-30
Updated: 2021-09-09
Unknown Phase
Artemisinin to Reduce The Symptoms of Schizophrenia
Completed
NCT00753506
Sheppard Pratt Health System
Schizoaffective Disorder, Schizophrenia
Start: 2008-08-31
End: 2010-05-31
Updated: 2012-02-28